UBI - Universal Biosensors

[Garpal Gumnut]

Will UBI cross the River Octoginta?

Resistance at 80c. Some nice volume today.



gg

 

[finicky]

Interesting thread read. Looks like the company has gone dynamic with the new CEO. Technology originally out of the CSIRO?

Dr Boreham's Crucible: Is Universal Biosensors really the 'Tesla or Apple' of handheld detection? - Stockhead

Almost a year into his reign at the sensor monitor, Universal Biosensors chief John Sharman doesn’t hold back about the company’s ability to disappoint.

stockhead.com.au

Strong buying, LT double bottom

All data monthly

 

[Country Lad]

Interesting read @finicky.
@Garpal Gumnut, this is my favourite sort of pattern and I will be very interested when it breaks $0.82. Thanks for the heads up.

 

[Garpal Gumnut]

In vino veritas?

UBI’s wine analytical test platform, Sentia. ... made first sales of its Sentia device and free SO2 test strips to companies operating in France, Italy, Germany, Spain, Portugal and Switzerland.

Verily, ad astra.

UBI continues its bullish run.

gg

 

[Garpal Gumnut]

@Dona Ferentes

Ubi sit UBI futura.

gg

 

[Dona Ferentes]

@Dona Ferentes

Ubi sit UBI futura.

gg

quando veniat

 

[Garpal Gumnut]

quando veniat

Vita sic est

gg

 

[Dona Ferentes]

Vita sic est

well read Ned

 

[Garpal Gumnut]

Where is UBI roamin’ at present?

gg

 

[aus_trader]

Where is UBI roamin’ at present?

gg

Showing strong share price growth, potentially setting up to go into high's beyond a dollar...

 

[Garpal Gumnut]

Showing strong share price growth, potentially setting up to go into high's beyond a dollar...

View attachment 129853

It doesn't seem to have the oomph atm or as we say in Gaul montre-moi du pèze.

Show patience or move on ??

gg

 

[frugal.rock]

It doesn't seem to have the oomph atm or as we say in Gaul montre-moi du pèze.

Show patience or move on ??

gg

Haven't looked at FA on this since it was around 15 cent.
I remember I liked the potential of the tech and market involved, but just never bought.

On a medium to long term basis, it's probably still a goer, however on a short term basis, the next week or 2 will be telling.

One would want to see it bouncing off current resistance and trend lines area as per @aus_trader chart, so around that 81 cent level.

Would be interested on what the wave guys predict, my guess on that front would be a break down past resistance to low/mid 70's before resuming up trend, just a guess though.
(Have decided I should look into the Elliot wave business a bit, an indicator that I haven't used).

There's one opinion for ye.

Edit; was just thinking outside the box and tech and health index's have had good runs, probably some chart correlation there and one might want to look at those index's when forming an opinion. (XHJ and XTX)

 

[aus_trader]

As @frugal.rock said, lot of the Biotech / Pharma stocks have been on the up lately... TLX, PTX, IMU, CUV, PME etc...

 

[Dona Ferentes]

the big one

April 2021; DIFM (Deakin U) and Swinburne have been working on the next generation of electrochemical biosensors and the Tn Antigen cancer biomarker for more than 5 years. Using UBI's platform technology we plan to deliver a cancer biosensor capable of identifying, staging and monitoring cancer from a finger prick of blood, using a portable hand held device. The knowledge and resources of DIFM and Swinburne will help deliver this as well as fast track the development of other biosensors we are working on.

and today

UBI has entered into an agreement with the Peter MacCallum Cancer Centre to supply cancer patient samples which will be used to develop and validate the performance of UBI's handheld point-of-care cancer biosensor for Tn Antigen. This agreement provides UBI with access to plasma samples collected from patients with colorectal, breast and prostate cancer as part of a Peter Mac research initiative. Trial results will be used to confirm the presence of Tn in multiple cancer types and determine the clinically relevant range of Tn concentrations.

The trial is scheduled to commence during October and results should be available during Q1 2022.

the Timeline goes out to 2024 before the Regulatory boxes are ticked.

... and creeping back up to the July highs

 

[finicky]

Goes beyond a distribution agreement, Vivelys wants in on sensor development for other wine testing factors. Not closely followed but I get the impression that UBI is sewing the French wine industry up.
"With its ability to measure free SO2 simply and immediately, and soon sugars and malic acid, Sentia strengthens Vivelys' solutions"
Won't be buying myself, it's a possible crash investment should it happen, as long as it isn't cash poor.

 

[finicky]

Holy smoke, just came across this. What the hell happened? I came very close to buying a first tranche of this before this crash. I have it on a watchlist but hadn't twigged to the plunge at all. I suppose I should read latest announcements b4 posting but can't be bothered tonight. What could do this to a biotech with such alluring technology?
Not Held.

Daily

 

[finicky]

So that's another $20m that UBI gets from the underwriting of the entitlement offer.
My understanding - the underwriter will pay 0.77 despite current share price of around 0.47

 

[finicky]

Viburnum Funds came through with its underwriting commitment and swallowed almost the entire entitlement offer @ 0.77 for $19.9m, whereas even today, upon the announcement of $25.2m banked cash, the share price is only 0.465. Rest of the $25.2m + fees came from a smaller placement.

 

[frugal.rock]

Chart update

 

[Garpal Gumnut]

@finicky @frugal.rock

I was burnt by this mob buying at 80c from memory and selling at 60c.

To paraphrase Plautus.

Est etiam, ubi profecto damnum praestet facere, quam spe lucri.

Perhaps they will rise like the phoenix.

gg